Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Ultragenyx (RARE) reported a Q3 loss of $1.40 per share, which is better than the Zacks Consensus Estimate of a $1.45 loss. This is an improvement from the $2.23 loss per share a year ago.
November 05, 2024 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ultragenyx reported a Q3 loss of $1.40 per share, better than the expected $1.45 loss, and an improvement from last year's $2.23 loss.
Ultragenyx's Q3 loss was smaller than expected and showed improvement from the previous year, which is a positive indicator for investors. This could lead to a short-term increase in stock price as the market reacts to better-than-expected earnings.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100